Epizyme Stock Filter Stocks by Fundamentals
EPZMDelisted Stock | USD 1.47 0.00 0.00% |
Epizyme fundamentals help investors to digest information that contributes to Epizyme's financial success or failures. It also enables traders to predict the movement of Epizyme Stock. The fundamental analysis module provides a way to measure Epizyme's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epizyme stock.
Epizyme |
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Epizyme Fundamentals
Return On Equity | -352.37 | |||
Return On Asset | -38.96 | |||
Operating Margin | (582.15) % | |||
Current Valuation | 334.85 M | |||
Shares Outstanding | 103.89 M | |||
Shares Owned By Insiders | 0.58 % | |||
Shares Owned By Institutions | 90.32 % | |||
Number Of Shares Shorted | 5.49 M | |||
Price To Earning | (7.76) X | |||
Price To Book | 1.00 X | |||
Price To Sales | 3.97 X | |||
Revenue | 38.49 M | |||
Gross Profit | 18.57 M | |||
EBITDA | (218.82 M) | |||
Net Income | (236.35 M) | |||
Cash And Equivalents | 199.73 M | |||
Cash Per Share | 1.21 X | |||
Total Debt | 254.44 M | |||
Current Ratio | 5.87 X | |||
Book Value Per Share | 1.46 X | |||
Cash Flow From Operations | (210.47 M) | |||
Short Ratio | 0.88 X | |||
Earnings Per Share | (2.29) X | |||
Price To Earnings To Growth | (0.03) X | |||
Number Of Employees | 250 | |||
Beta | -0.45 | |||
Market Capitalization | 152.73 M | |||
Total Asset | 217.9 M | |||
Retained Earnings | (776.94 M) | |||
Working Capital | 194.61 M | |||
Current Asset | 213.06 M | |||
Current Liabilities | 18.45 M | |||
Z Score | -7.5 |
About Epizyme Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Epizyme's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epizyme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epizyme based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Epizyme
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Epizyme position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epizyme will appreciate offsetting losses from the drop in the long position's value.Moving together with Epizyme Stock
0.81 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
0.79 | NONOF | Novo Nordisk AS | PairCorr |
Moving against Epizyme Stock
0.86 | ZTLLF | Zonetail | PairCorr |
0.75 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
0.67 | WXIBF | WuXi Biologics | PairCorr |
0.63 | CSLLY | CSL | PairCorr |
0.62 | GLABF | Gemina Laboratories | PairCorr |
The ability to find closely correlated positions to Epizyme could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Epizyme when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Epizyme - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Epizyme to buy it.
The correlation of Epizyme is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Epizyme moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Epizyme moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Epizyme can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Epizyme information on this page should be used as a complementary analysis to other Epizyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Epizyme Stock
If you are still planning to invest in Epizyme check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Epizyme's history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |